Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists
- 11 September 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Targets
- Vol. 11 (9) , 1179-1188
Abstract
Primary headaches, for example, migraine and cluster headaches represent the most prevalent neurological disorders, affecting up to 15 – 20% of the adult population. There is a clear association between head pain and the release of calcitonin gene-related peptide (CGRP). In this review the role of CGRP in human cranial circulation is described and the role for specific CGRP antagonism elucidated. It is well known that triptans (5-HT1B/1D agonist) alleviate headache in part through normalisation of CGRP levels. The central role of CGRP in migraine pathophysiology has resulted in the development of small-molecule CGRP antagonists with no cardiovascular side effects. Such compounds have high selectivity for human CGRP receptors and are efficacious in the relief of acute migraine attacks. Research indicates that they effect the abluminal side of the blood-brain barrier and that they are not vasoconstrictive, providing a new dimension in therapy.Keywords
This publication has 58 references indexed in Scilit:
- Inhibitory effect of BIBN4096BS, CGRP8–37, a CGRP antibody and an RNA‐Spiegelmer on CGRP induced vasodilatation in the perfused and non‐perfused rat middle cerebral arteryBritish Journal of Pharmacology, 2007
- Characterisation of CGRP receptors in the human isolated middle meningeal arteryLife Sciences, 2006
- Neurobiology in primary headachesBrain Research Reviews, 2005
- CGRP Release and c-fos Expression within Trigeminal Nucleus Caudalis of the Rat following Glyceryltrinitrate InfusionCephalalgia, 2005
- Calcitonin Gene-Related Peptide Antagonists as Treatments of Migraine and Other Primary HeadachesDrugs, 2005
- Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the ratBritish Journal of Pharmacology, 2004
- Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin‐induced dural dilationBritish Journal of Pharmacology, 2003
- Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patientsBrain, 1997
- Calcitonin gene-related peptide: Vasoactive effects and potential therapeutic roleGeneral Pharmacology: The Vascular System, 1996
- Brain Stem Terminations of the Trigeminal and Upper Spinal Ganglia Innervation of the Cerebrovascular System: WGA-HRP Transganglionic StudyJournal of Cerebral Blood Flow & Metabolism, 1988